成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 185379-40-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 185379-40-2
Chemical Structure| 185379-40-2
Structure of 185379-40-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 185379-40-2 ]

Related Doc. of [ 185379-40-2 ]

Alternatived Products of [ 185379-40-2 ]
Product Citations

Product Details of [ 185379-40-2 ]

CAS No. :185379-40-2 MDL No. :MFCD00672564
Formula : C23H20N2O4 Boiling Point : No data available
Linear Structure Formula :- InChI Key :DXIVJCDZOMUITR-NRFANRHFSA-N
M.W : 388.42 Pubchem ID :978320
Synonyms :

Calculated chemistry of [ 185379-40-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 29
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.17
Num. rotatable bonds : 8
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 107.45
TPSA : 88.52 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.98
Log Po/w (XLOGP3) : 3.61
Log Po/w (WLOGP) : 3.62
Log Po/w (MLOGP) : 2.4
Log Po/w (SILICOS-IT) : 3.47
Consensus Log Po/w : 3.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -4.45
Solubility : 0.0137 mg/ml ; 0.0000352 mol/l
Class : Moderately soluble
Log S (Ali) : -5.16
Solubility : 0.00271 mg/ml ; 0.00000698 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.0
Solubility : 0.0000384 mg/ml ; 0.0000000989 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.86

Safety of [ 185379-40-2 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H302-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 185379-40-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 185379-40-2 ]

[ 185379-40-2 ] Synthesis Path-Downstream   1~1

  • 1
  • Fmoc-Leu-Wang resin [ No CAS ]
  • [ 29022-11-5 ]
  • [ 47375-34-8 ]
  • [ 185379-40-2 ]
  • H<SUB>2</SUB>N-Tyr-Gly-Gly-(2-pyridyl)Ala-Leu-OH [ No CAS ]
YieldReaction ConditionsOperation in experiment
10.8% General procedure: Peptides were synthesized using a solid phase peptide synthesis protocol using an Aapptec FocusXC automated peptide synthesizer coupled with a heating system using the Fmoc chemistry andWang resin as solid support [34]. To prepare the resin for synthesis, a reaction vessel equipped with asintered glass bottom was charged with Fmoc-Leu-Wang resin (0.2 mM), and swelled in a mixture ofdichloromethane and DMF (1:1) for 15 min. The resin was then transferred to a peptide synthesizerreaction vessel. The resin was deprotected twice using 20% piperidine in DMF for 5 min at 70 C.Subsequently, an Fmoc-protected amino acid was double coupled with the Leucine-wang resin bytreating with N,N'-diisopropylcarbodiimide (3.0 equiv., 0.2 M in DMF) and Oxyma (3.0 equiv., 0.2 M inDMF) at 70 C for 8 min. Completion of coupling reactions was monitored by a Kaiser’s test for theinitial peptide [40]. Each coupling was followed by removal of the Fmoc group using 20% piperidinein DMF at 70 C for 5 min and repeated once. The cycle of the Fmoc removal and coupling wasrepeated with subsequent Fmoc-protected amino acids to generate the desired resin-bound peptide.Cleavage of the peptide from resin and concomitant deprotection of the side chain protecting groupswas carried out by shaking in TFA/triisopropylsilane/H20 (95/2.5/2.5; 5 mL), at ambient temperature for3 h. Subsequent filtration aorded the peptide in the filtrate and the volume was reduced to 0.2 mL.Then, the crude peptides were precipitated by adding cold diethyl ether, and the crude peptides werethen purified by RP-HPLC. Synthesized peptides were characterized by NMR, and the high-resolutionmass spectroscopy.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 185379-40-2 ]

Amino Acid Derivatives

Chemical Structure| 185379-39-9

[ 185379-39-9 ]

Fmoc-2-D-Pal-OH

Similarity: 1.00

Chemical Structure| 142994-45-4

[ 142994-45-4 ]

Fmoc-D-3-Pal-OH

Similarity: 0.98

Chemical Structure| 175453-07-3

[ 175453-07-3 ]

Fmoc-3-Pal-OH

Similarity: 0.95

Chemical Structure| 205528-30-9

[ 205528-30-9 ]

Fmoc-D-4-Pal-OH

Similarity: 0.93

Chemical Structure| 169555-95-7

[ 169555-95-7 ]

Fmoc-4-Pal-OH

Similarity: 0.91

; ;